Ivy Value Fund

100 Independence,610 Market Street
Philadelphia , PA, 19106

Rank

Rank Universe

Summary

The fund seeks capital appreciation by investing in mega and large-size companies in the United States.

The investment process is designed to highlight undervalued companies that are trading at a significant discount relative to their estimated intrinsic value.

The process focuses on companies that may be out of favor for temporary reasons but have prospects for long-term continued and consistent growth.

The process starts with a list of companies in the benchmark index and narrows the list to include those that

Link

Directors

Jun 14, 2023
  • Thomas K. Whitford
  • Shawn K. Lytle
  • Frances A. Sevilla-Sacasa
  • Joseph W. Chow
  • Janet L. Yeomans
  • Christianna Wood
  • John A. Fry
  • Ann D. Borowiec
  • Sandra A.J. Lawrence
  • Joseph Harroz, Jr.
  • H. Jeffrey Dobbs
  • Jerome D. Abernathy

Chief Compliance Officer

  • William Speacht

Fund Manager(s)

  • Matthew Norris

Price

  • $17.9 ( +0.2 ) Jul 26, 2024 Last Close
  • Net Assets
  • $517.8M
    Feb 27, 2024
    More
  • 52-Week High/Low
  • $0 - $0
  • Turnover
  • 60%
  • Expense Ratio
  • 0.74%

Company Name

Holding

US Bancorp 3.21 %
TJX Cos Inc/The 3.17 %
Dover Corp 3.17 %
Cognizant Technology Solutions 3.15 %
Fidelity National Information 3.12 %
Cigna Group/The 3.09 %
Walt Disney Co/The 3.03 %
CVS Health Corp 2.82 %
Baxter International Inc 2.59 %
MSILF Government Portfolio 0.17 %
More

Documents

Prospectus

Annual Reports

Performance

YTD

1.8%

3 Year

-36.73%

5 Year

-26.22%

Best

18.22%

2021

Worst

-22.21%

2022

Alpha

IVALX Russell 1000

Chart +